Q-linea AB (publ) (QLINEA.ST)

SEK 0.97

(-1.62%)

Operating Expenses Summary of Q-linea AB (publ)

  • Q-linea AB (publ)'s latest annual operating expenses in 2023 was -43 Thousand SEK , down -100.02% from previous year.
  • Q-linea AB (publ)'s latest quarterly operating expenses in 2024 Q2 was 62.64 Million SEK , up 12.99% from previous quarter.
  • Q-linea AB (publ) reported a annual operating expenses of 240.42 Million SEK in annual operating expenses 2022, up 15.44% from previous year.
  • Q-linea AB (publ) reported a annual operating expenses of 208.25 Million SEK in annual operating expenses 2021, up 9.91% from previous year.
  • Q-linea AB (publ) reported a quarterly operating expenses of 62.64 Million SEK for 2024 Q2, up 12.99% from previous quarter.
  • Q-linea AB (publ) reported a quarterly operating expenses of 62.47 Million SEK for 2023 Q2, down -3.67% from previous quarter.

Annual Operating Expenses Chart of Q-linea AB (publ) (2023 - 2016)

Historical Annual Operating Expenses of Q-linea AB (publ) (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 -43 Thousand SEK -100.02%
2022 240.42 Million SEK 15.44%
2021 208.25 Million SEK 9.91%
2020 189.47 Million SEK 25.24%
2019 151.28 Million SEK 41.03%
2018 107.27 Million SEK 81.74%
2017 59.02 Million SEK 12.23%
2016 52.59 Million SEK 0.0%

Peer Operating Expenses Comparison of Q-linea AB (publ)

Name Operating Expenses Operating Expenses Difference
AddLife AB (publ) 3.01 Billion SEK 100.001%
Biotage AB (publ) 637 Million SEK 100.007%
Bonesupport Holding AB (publ) 510.93 Million SEK 100.008%
Doxa AB (publ) -259.5 Million SEK 99.983%
Elekta AB (publ) 3.39 Billion SEK 100.001%
iZafe Group AB (publ) 35.92 Million SEK 100.12%
Ortivus AB (publ) 48.45 Million SEK 100.089%
Ortivus AB (publ) 48.45 Million SEK 100.089%
S2Medical AB (publ) 20.3 Million SEK 100.212%
Synsam AB (publ) 3.76 Billion SEK 100.001%